The cost of private menopause care depends on what is actually being purchased: an initial consultation, tests, a prescription service, ongoing review or a broader programme. There is no single price that meaningfully covers all of these. A useful comparison separates the components and considers the period of care you are likely to need.
This guide does not invent a market average or present old advertised fees as current quotes. It provides a framework for obtaining and comparing accurate prices directly from providers, while keeping cost separate from clinical suitability.
Define the service before comparing the price
A menopause consultation, a gynecological investigation, psychotherapy and a wellness retreat are different services. Comparing their headline prices as though they deliver the same outcome can be misleading. Start by identifying the clinical question and the professionals or facilities required to address it.
For example, a remote consultation may cover history-taking and a treatment discussion but not examination, ultrasound or laboratory work. A package described as comprehensive may include wellbeing sessions while excluding the investigation you actually need. Ask for the scope in writing.
Our care-options comparison explains the different categories. Once the service is clear, cost questions become more precise: what is included, what is optional and what is likely to be needed next?
The initial consultation is only one component
Check the appointment length, practitioner, format and deliverables. Does the fee include reviewing records beforehand, a written summary, an initial prescription decision or a follow-up message? A longer appointment may offer more time, but its value depends on how that time addresses your concerns.
Ask whether a first appointment can lead to a recommendation for no medication or referral elsewhere without pressure to buy a package. An assessment should be a clinical service in its own right, not merely a sales stage before compulsory testing or treatment.
Also check cancellation and rescheduling terms. These matter when symptoms, caregiving or work make attendance uncertain. A headline fee is not the complete financial commitment if deposits are nonrefundable or changes incur substantial charges.
Tests should have a clinical purpose
Routine hormone testing is not always required for a typical menopause assessment. Tests can be appropriate for particular questions, but a larger panel is not automatically more thorough or more useful. Ask why each proposed investigation is needed and how the result will change care. [1]
Separate the cost of collecting the sample, laboratory analysis and clinician interpretation. Ask whether an abnormal result leads to another paid appointment and whether the service arranges further care. A low-priced panel can become expensive if the report creates unresolved questions without a responsible clinician.
Bring relevant recent results to reduce unnecessary duplication, while recognising that a clinician may reasonably need a new test when circumstances have changed. Our testing guide explains how to distinguish purposeful investigation from a broad hormone-optimisation package.
Prescription fees and medicine costs are different
A clinic may charge for issuing or renewing a prescription separately from the pharmacy’s charge for the medicine. Ask about both. Also check delivery, dispensing arrangements and what happens when a product is unavailable or needs changing.
Compare the actual preparation and quantity supplied. Different routes, formulations and combinations may have different costs and cannot always be substituted without clinical advice. Do not assume the cheapest product is equivalent or change treatment independently to reduce expense.
Ask whether another clinician is expected to continue prescribing and whether that arrangement has been agreed. A private recommendation does not automatically transfer responsibility to a public-health service or a clinician who has not accepted the plan. Financial planning should reflect the real prescribing pathway.
Follow-up and monitoring need to be budgeted
Review is part of safe treatment, not an optional extra added only when something goes wrong. Ask when it is expected, who conducts it, how much it costs and whether required monitoring is included. Some medicines have specific safety-testing requirements that create ongoing responsibilities. [2] [3]
Clarify the difference between routine review, brief questions and urgent advice. A messaging service may not be monitored outside business hours or may exclude new symptoms. Understand those limits rather than assuming a membership provides continuous clinical availability.
Request a realistic estimate for the first assessment period, including an expected review and medicine supply. Comparing only the first consultation can favour a service whose essential later charges are higher. A written estimate also makes it easier to identify changes before agreeing to them.
Insurance and public care can change the calculation
Where insurance is involved, confirm coverage for the exact provider, appointment, tests and medicines. A clinic accepting an insurer does not necessarily mean every component is covered under your plan. Ask both the provider and insurer for the information needed to estimate your own payment.
In systems combining public and private care, clarify which service is responsible for each part. You may choose a private consultation but still need a separate public pathway for investigation or long-term treatment. Do not assume that all recommendations will automatically be adopted elsewhere.
Keep copies of quotes, coverage confirmations and clinical recommendations. If the plan changes, ask for an updated estimate rather than relying on an earlier package description. Cost clarity is especially important when care involves several professionals or an external laboratory.
Memberships and packages need close reading
A recurring fee may be useful when it includes services you genuinely need, but the details matter. Ask how many appointments are included, whether the same clinician is available, what messaging covers and whether unused services expire. Identify automatic renewals and the process for cancelling.
A package should not require unnecessary tests or treatments to justify its price. Ask whether components can be declined and whether the fee changes accordingly. Clinical decisions should remain individual rather than follow the structure of a commercial bundle.
Be cautious about urgency-based offers that pressure you to commit before reviewing terms. Menopause care often involves decisions that can be considered carefully unless there is a separate urgent clinical issue. A provider should explain the care pathway without implying that a discounted package is your only chance to improve.
Residential treatment and wellness stays are separate budgets
A residential mental-health programme or a premium wellness stay is not simply a more expensive menopause appointment. Accommodation, staffing, clinical intensity, hospitality and duration all contribute to the quote. The clinical need and service category should be established before comparing such proposals.
THE BALANCE, COGNIFUL and SENSES are presented in this guide according to their different published programme types. This page does not quote a verified current price for them or establish a menopause-specific package. Request a written proposal directly and verify the actual location, scope and suitability. [4]
A large fee does not guarantee specialist menopause care, a better outcome or the ability to manage emergencies. Ask which clinicians are involved, what is included and what would trigger transfer to another service. The luxury-wellness guide explains how to evaluate premium features without confusing them with clinical evidence.
Travel and follow-up abroad add other costs
When considering care abroad, include transport, accommodation outside the programme, travel insurance, accompanying-person costs and changes to flights. Ask what happens financially if treatment is delayed, extended or interrupted. A programme quote may not cover those consequences.
Prescription continuity, tests at home and follow-up after returning can also add cost. Verify whether recommendations can be implemented by a clinician in your country and who is responsible if a problem emerges later. A discharge summary is useful, but it is not the same as an accepted ongoing care arrangement.
Our care abroad guide provides a fuller checklist. The relevant comparison is the whole pathway, not only the advertised daily or weekly rate. Travel should be justified by the care need and personal circumstances, not by assuming distance creates expertise.
A simple way to compare two quotes
Use the same headings for each option: initial assessment, tests, medicines, follow-up, messaging, additional referrals and cancellation terms. Record the quoted amount, currency, date and any assumptions. Mark unanswered questions clearly instead of treating missing information as included.
Then compare the clinical scope alongside the cost. Which option can assess the actual concern, provide the required examination and manage treatment safely? A cheaper service that cannot do so may create another appointment; a more expensive one may include services you do not need.
Use our care checklist to organise the answers without producing a provider score. The goal is an informed decision about appropriate care and a realistic financial commitment, not finding a universal cheapest or most luxurious winner.
For a practical comparison, ask each provider to quote the same scenario: one assessment, the investigations the clinician considers necessary, an initial medicine supply if prescribed and the planned first review. Keep optional wellbeing services separate. Record whether the estimate assumes an uncomplicated consultation or may change after assessment. This makes differences visible without inventing a standard market price or implying that every patient needs the same treatment.
Sources you can inspect
- NICE: Menopause: identification and management (NG23), recommendations
- NHS: When to take hormone replacement therapy (HRT)
- US Food and Drug Administration: Veozah (fezolinetant): serious liver injury warning
- THE BALANCE group: Our wider group
Sources consulted 21 September 2026. This date records source consultation, not individual medical review. Provider descriptions are self-published and require direct verification.